Your life sciences partner across the entire product lifecycle

QbD Group is the European Expert specialized in quality assurance, regulatory compliance, clinical services and digital solutions for the Medical Device, IVD, Pharma and Biotech industry.

QbD Group is a service partner for companies worldwide to ensure they meet the highest quality and safety standards, from idea to patient.

Discover our services

Trusted expertise

Over 750 specialists with deep expertise across a wide range of life sciences sectors, offering unmatched knowledge and insights to address complex challenges.

Full lifecycle support

Providing comprehensive solutions at every stage, from early-stage development through to patient care, ensuring seamless progression of your projects.

Tailored solutions

Delivering fully integrated services, customized to your unique needs, ensuring efficient and effective solutions from start to finish.

Regulatory expertise

Offering extensive expertise in navigating global regulatory landscapes, ensuring smooth and compliant pathways for your products.

Agile integration

Seamlessly integrating with your team, adapting to your specific requirements with flexibility and responsiveness to deliver results.

Global presence

Delivering high-quality services across Europe, China, Latin America, and beyond, enabling you to access key markets worldwide.

Industries we cover

We specialize in supporting life sciences companies across various key industries.

With expertise in each sector, we help navigate complex challenges to bring innovative products to market efficiently and compliantly. Discover more about our core industries here.

Pharma & Biotech

Medical Devices

In Vitro Diagnostics

Our services

QbD Group offers a comprehensive suite of services that cover critical areas in life sciences product development, launch and commercialization.

Explore our 8 specialized services designed to ensure success at every stage.

Regulatory Affairs

Quality Assurance

Lab Services

Qualification & Validation

Vigilance

Clinical

Software Solutions & Services

Toxicology

Latest news

10 Feb 2025

Azierta fully integrated into QbD Group

10 Feb 2025

QbD Group unveils evolved brand identity, reflecting...

3 Feb 2025

QbD Group strengthens global leadership with the...

4 Dec 2024

QbD Group announces acquisition of SciencePharma,...

Discover our expert content

Whitepaper

ICH Stability Studies on Pharmaceuticals

This whitepaper discusses the importance of different methods for testing the stability of pharmaceutical products, stability study guidelines, and other aspects related to the stability of pharmaceutical products.

Whitepaper

EU GMP: How to import your products into the EU?

Are you a medicinal product manufacturer looking to import your products into the EU in line with the latest EU-GMP import regulations? Download our guide.

Case study

Scalable MSAT validation support for seamless compliance & efficiency

Discover how QbD Group helped a global pharmaceutical company address fluctuating validation demands across multiple teams.

Case study

Restoring manufacturing timelines through expert deviation management

Discover how QbD Group helped a leading biotechnology company overcome a backlog of deviations, restoring timely batch release through expert QA support.

Blog

Establishing and Maintaining the Right Level of Clinical Evidence under the EU IVDR

We’re proud to highlight a new publication by Pieter Bogaert, PhD—senior...

Blog

Post-Market Surveillance (PMS) and Post-Market Clinical Follow-Up (PMCF) under the MDR: Ensuring safety and performance

With the introduction of the Medical Device Regulation (MDR), the...

Blog

What Makes Usability Testing Crucial for Near-Patient and Self-Testing Devices under IVDR?

It shouldn’t be a surprise that today, “Near-Patient Testing (NPT)” and...

Blog

When does Annex XIV apply in Performance Studies, and what key documentation is needed for compliance?

In the European regulatory landscape, conducting performance studies for in...

Discover all